(Q44352771)

English

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

tetrahydrocannabinol

0 references

0 references

0 references

0 references

cannabinoid receptor

0 references

Jorge Manzanares

object named as

J Manzanares

1

0 references

author name string

J Corchero

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

J A Fuentes

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

839

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

173-179

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Effect of Intraventricular β-Endorphin and Morphine on Hypothalamic-Pituitary-Adrenal Activity and the Release of Pituitary β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Effects of opioids on the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Corticotrophin and corticosterone secretion following Δ1-tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Long-term behavioral effects of perinatal exposure to delta 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

A direct radioimmunoassay for the determination of adrenocorticotropic hormone (ACTH) and a clinical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901756-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(99)01756-4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44352771&oldid=2019691935"